Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000061957

Apexbio Technology LLC EPZ5676 1380288-87-8 10mM (in 1mL DMSO)
SDP

Catalog No. 5000061957
Encompass_Preferred

EPZ5676 (CAS 1380288-87-8) is a selective inhibitor targeting DOT1L a histone methyltransferase responsible for H3K79 methylation Structural studies indicate EPZ5676 occupies the enzyme s S-adenosylmethionine (SAM) binding pocket inducing conformational changes and partial opening beyond the SAM hydrophobic pocket EPZ5676 displays potent inhibitory activity against DOT1L (IC50 0 8 nM) with markedly lower affinity for other methyltransferases In MLL-rearranged leukemia models EPZ5676 reduces H3K79 methylation inhibits MLL fusion target gene expression and induces cytotoxicity in leukemia cell lines harboring MLL translocations

Catalog No. 50-000-61957 Supplier Apexbio Technology LLC Supplier No. A41665.1
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EPZ5676 (CAS 1380288-87-8) is a selective inhibitor targeting DOT1L a histone methyltransferase responsible for H3K79 methylation Structural studies indicate EPZ5676 occupies the enzyme s S-adenosylmethionine (SAM) binding pocket inducing conformational changes and partial opening beyond the SAM hydrophobic pocket EPZ5676 displays potent inhibitory activity against DOT1L (IC50 0 8 nM) with markedly lower affinity for other methyltransferases In MLL-rearranged leukemia models EPZ5676 reduces H3K79 methylation inhibits MLL fusion target gene expression and induces cytotoxicity in leukemia cell lines harboring MLL translocations

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.